Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 373574, 9 pages
http://dx.doi.org/10.1155/2015/373574
Research Article

miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1

1Department of Surgery, The Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, China
2School of Electronics and Information Engineering, Tongji University, Shanghai 201804, China
3Department of Clinical Laboratory, Tongde Hospital of Zhejiang Province, 234 Gucui Road, Hangzhou 310012, China
4Department of Ophthalmology, Xinhua Hospital, School of Medicine, Jiaotong University, Shanghai 200092, China

Received 24 March 2015; Revised 14 May 2015; Accepted 24 May 2015

Academic Editor: Franco M. Buonaguro

Copyright © 2015 Jingpei Long et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jingpei Long, Zhiwei Ji, Kai Jiang, Zhaoyang Wang, and Guanmin Meng, “miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1,” BioMed Research International, vol. 2015, Article ID 373574, 9 pages, 2015. doi:10.1155/2015/373574